# OnCo record paper-espac-5-neoadjuvant-borderline-resectable-pancreatic-lancet-gastro-hep-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-espac-5-neoadjuvant-borderline-resectable-pancreatic-lancet-gastro-hep-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-espac-5-neoadjuvant-borderline-resectable-pancreatic-lancet-gastro-hep-2023" ;
  schema:name "ESPAC5: immediate surgery versus short-course neoadjuvant chemotherapy or chemoradiotherapy for borderline resectable pancreatic cancer"@en ;
  schema:description "In this four-arm British trial, two months of chemotherapy before surgery for borderline resectable pancreatic cancer doubled the share of patients alive at one year compared with operating straight away, even though the same proportion got to an operation."@en ;
  schema:url <https://onco.cc/key-papers/paper-espac-5-neoadjuvant-borderline-resectable-pancreatic-lancet-gastro-hep-2023/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S2468-1253(22)00348-X>, <https://pubmed.ncbi.nlm.nih.gov/36521500/> ;
  schema:sameAs <https://doi.org/10.1016/S2468-1253(22)00348-X> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Ghaneh P, Palmer D, Cicconi S, et al." ;
  onco:cancers <https://onco.cc/cancers/borderline-resectable-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/folfirinox/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/capecitabine/> .